Iovance Biotherapeutics (IOVA) Other Gross PP&E Adjustments: 2013-2025
Historic Other Gross PP&E Adjustments for Iovance Biotherapeutics (IOVA) over the last 5 years, with Sep 2025 value amounting to $117.4 million.
- Iovance Biotherapeutics' Other Gross PP&E Adjustments fell 18.26% to $117.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $352.2 million, marking a year-over-year decrease of 8.26%. This contributed to the annual value of $49.0 million for FY2024, which is 3.60% down from last year.
- Iovance Biotherapeutics' Other Gross PP&E Adjustments amounted to $117.4 million in Q3 2025, which was up 14.07% from $102.9 million recorded in Q2 2025.
- Iovance Biotherapeutics' 5-year Other Gross PP&E Adjustments high stood at $143.6 million for Q3 2024, and its period low was $49.0 million during Q4 2024.
- In the last 3 years, Iovance Biotherapeutics' Other Gross PP&E Adjustments had a median value of $68.2 million in 2023 and averaged $83.6 million.
- In the last 5 years, Iovance Biotherapeutics' Other Gross PP&E Adjustments soared by 125.95% in 2024 and then fell by 23.21% in 2025.
- Over the past 3 years, Iovance Biotherapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $50.8 million in 2023, then dropped by 3.60% to $49.0 million in 2024, then decreased by 18.26% to $117.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at $117.4 million for Q3 2025, versus $102.9 million for Q2 2025 and $82.8 million for Q1 2025.